Trabeculectomy with mitomycin c versus Ahmed Glaucoma Valve implantation in refractory glaucoma

To compare the efficacy of Ahmed glaucoma valve implantation versus trabeculectomy with mitomycin-C in refractory glaucoma - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/10/075027

Enrollment

Registered

2024-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H408- Other glaucoma

Interventions

Intervention1: Subconjunctival Ahmed glaucoma valve implantation: The implant Ahmed glaucoma valve will be implanted in the subconjunctival space of the eye . The purpose of implant is to drain aqueou

Eligibility

Inclusion criteria

Inclusion criteria: Age above 40 years Patient consenting for trial Patient not responding to maximum medical therapy or conventional surgical therapy

Exclusion criteria

Exclusion criteria: Age below 40 year Silicone oil filled eyes Patient not consenting for trial Patient with corneal or scleral pathologies

Design outcomes

Primary

Measure	Time frame
The Intraocular pressure(IOP) will be the primary outcome measureTimepoint: 1 week,4 weeks,3 months	—

Secondary

Measure	Time frame
Assesement of visual acuity and complications related to the proceduresTimepoint: 1month,3months	—

Countries

India

Contacts

Public ContactDeepti joshi

UPUMS saifai

deeptijoshidj10@gmail.com7830433212

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026